BTC Health (ASX:BTC) 3-Year ROIIC % : 4.45% (As of Jun. 2025) — Near Median


What is BTC Health 3-Year ROIIC %?

BTC Health ASX:BTC 3-Year ROIIC % is 4.45 as of Jun. 2025, which is at its 10-year median of 4.45. The stock has 3 warning signs investors should review. Among 1,320 Biotechnology companies, BTC Health ranks better than 57.42% on this metric.

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. BTC Health's 3-Year ROIIC % for the quarter that ended in Jun. 2025 was 4.45%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for BTC Health's 3-Year ROIIC % or its related term are showing as below:

ASX:BTC's 3-Year ROIIC % is ranked better than
57.42% of 1320 companies
in the Biotechnology industry
Industry Median: -4.42 vs ASX:BTC: 4.45

BTC Health  (ASX:BTC) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


BTC Health 3-Year ROIIC % Related Terms


BTC Health 3-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for BTC Health's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BTC Health 3-Year ROIIC % Chart

BTC Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.67 8.26 2.07 5.19 4.45

BTC Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 5.19 0.00 4.45 0.00

ASX:BTC vs VRTX, REGN, ALNY: 3-Year ROIIC % Comparison

For the Biotechnology subindustry, BTC Health's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BTC Health 3-Year ROIIC % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BTC Health's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where BTC Health's 3-Year ROIIC % falls into.



BTC Health 3-Year ROIIC % Calculation

BTC Health's 3-Year ROIIC % for the quarter that ended in Jun. 2025 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -0.675 (Jun. 2025) - -0.577 (Jun. 2022) )/( 8.825 (Jun. 2025) - 11.029 (Jun. 2022) )
=-0.098/-2.204
=4.45%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 3-Year ROIIC % →
What does a 3-Year ROIIC % of 4.45 mean?
BTC Health (ASX:BTC) has a 3-Year ROIIC % of 4.45 as of Jun. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on BTC Health and its competitors. This is near median its historical median of 4.45. According to the industry distribution chart, BTC Health ranks #562 out of 1320 companies in the Biotechnology industry, placing it in the top 42.6%.
Is BTC Health's 3-Year ROIIC % too high?
BTC Health's current 3-Year ROIIC % of 4.45 is near median its 10-year median of 4.45. Based on the distribution chart, BTC Health ranks #562 out of 1320 companies in the Biotechnology industry, which is above the industry midpoint.
How does BTC Health's 3-Year ROIIC % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BTC Health ranks #562 out of 1320 companies for 3-Year ROIIC %. This puts BTC Health in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on BTC Health and its competitors. BTC Health's current 3-Year ROIIC % is 4.45, which is near median its own 10-year median of 4.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BTC Health stock overvalued right now?
BTC Health (ASX:BTC) has a current 3-Year ROIIC % of 4.45. The current 3-Year ROIIC % is 4.45, which is near median its 10-year median of 4.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For BTC Health (ASX:BTC), the current 3-Year ROIIC % is 4.45 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BTC Health Business Description

Address 10 Oxley Road, Level 1, Hawthorn, Melbourne, VIC, AUS, 3122
BTC Health Ltd is a pooled development fund focused on seeking new investment opportunities in entities operating in the biotechnology and life sciences sectors. Its sole operating segment involves making and managing healthcare ventures. The company's products include Elasto-Q, Rythmic Infusion Pumps, Tiva, Infusion and Nerve Catheter Kits, Biopsy Needles, Radiological Markers, Rebellion Bone Removal System, Bonopty Coaxial Bone Biopsy, ECLS (Extracorporeal Life Support) Oxygenators, Pears, Valves, NEOLA, and LPS Adsorber. Geographically, it operates in Australia.